BDNF and TrkB expression is significantly elevated in various cancer cells, including cervical cancer, highlighting their potential as targets for therapeutic intervention to improve patient survival and develop new treatments for cervical cancer metastasis. The gene discussed is NTRK2; the disease is cervical cancer.